BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16685374)

  • 1. Thymidylate synthase expression in oral squamous cell carcinoma predicts response to S-1.
    Harada K; Kawashima Y; Yoshida H; Sato M
    Oncol Rep; 2006 Jun; 15(6):1417-23. PubMed ID: 16685374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy.
    Kinoshita M; Kodera Y; Hibi K; Nakayama G; Inoue T; Ohashi N; Ito Y; Koike M; Fujiwara M; Nakao A
    Anticancer Res; 2007; 27(2):851-6. PubMed ID: 17465211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of mRNA levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase of colorectal cancer--relationships among mRNA levels in association with response to 5-FU based treatment].
    Ishida H; Shirakawa K; Ohsawa T; Sobajima J; Hayashi Y; Nakada H; Yokoyama M; Hashimoto D
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1929-34. PubMed ID: 16282729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.
    Tateishi Y; Tatemoto Y; Ohno S; Morishita K; Ueta E; Yamamoto T
    Cancer Lett; 2009 Feb; 274(2):187-93. PubMed ID: 18986760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
    Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M
    Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, orotate phosphoribosyltransferase mRNA expression in lung cancer metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration: a pilot study.
    Nakajima T; Yasufuku K; Suzuki M; Hiroshima K; Nakatani Y; Fujisawa T; Yoshino I
    Clin Lung Cancer; 2011 Sep; 12(5):293-7. PubMed ID: 21791367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis].
    Li HX; Zh S; Zhang YH; Risberg B; Karlsson MG; Nesland JM
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):669-72. PubMed ID: 15777505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
    Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
    Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Hölscher AH; Danenberg PV; Brabender J
    Clin Lung Cancer; 2010 Sep; 11(5):328-34. PubMed ID: 20837458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.
    Kaira K; Serizawa M; Koh Y; Miura S; Kaira R; Abe M; Nakagawa K; Ohde Y; Okumura T; Murakami H; Tsuya A; Nakamura Y; Naito T; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
    Lung Cancer; 2011 Dec; 74(3):419-25. PubMed ID: 21550686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of mRNA levels of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in diffusely infiltrating colorectal cancer].
    Ishibashi K; Sobajima J; Ohsawa T; Yokoyama M; Miyazaki T; Nakada H; Gonda T; Ishida H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1073-7. PubMed ID: 17637543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 5-fluorouracil-related gene expression levels between adenocarcinomas and squamous cell carcinomas of the lung.
    Ishihama H; Chida M; Araki O; Karube Y; Seki N; Tamura M; Umezu H; Honma K; Masawa N; Miyoshi S
    Jpn J Clin Oncol; 2009 Jan; 39(1):33-6. PubMed ID: 19015148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.
    Salonga D; Danenberg KD; Johnson M; Metzger R; Groshen S; Tsao-Wei DD; Lenz HJ; Leichman CG; Leichman L; Diasio RB; Danenberg PV
    Clin Cancer Res; 2000 Apr; 6(4):1322-7. PubMed ID: 10778957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
    Oeda M; Yoshida K; Sanada Y; Wada Y; Suzuki T; Mizuiri H; Konishi K; Shigematsu H; Tanabe K; Fukushima M
    Oncol Rep; 2006 Dec; 16(6):1165-72. PubMed ID: 17089033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
    Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.